{
  "source": "facebook",
  "source_id": "001",
  "url": "https://www.facebook.com/AmylyxPharma/posts/001",
  "permalink": null,
  "title": null,
  "text": "Amylyx Pharmaceuticals is enrolling patients in a Phase 3 clinical trial for avexitide, an investigational treatment for post-bariatric hypoglycemia (PBH). If you've had bariatric surgery and experience low blood sugar episodes after meals, you may be eligible. Visit our website to learn more about participation. #ClinicalTrial #PBH #BariatricSurgery",
  "parent_source": null,
  "subsource": "Amylyx Pharmaceuticals",
  "author": {
    "id": "fb_user_001",
    "name": "User M",
    "handle": "user_m",
    "gender": null,
    "age": null,
    "subscribers": 15200
  },
  "country": "US",
  "published_at": "2025-04-25T10:00:00+00:00",
  "language": "eng",
  "metrics": {
    "likes": 124,
    "comments": 38,
    "shares": 22
  },
  "topics": [
    "bariatric_surgery",
    "clinical_trial"
  ],
  "symptoms": [],
  "treatments": [
    "avexitide"
  ],
  "conditions": [
    "PBH"
  ],
  "companies": [
    "Amylyx"
  ],
  "engagement_score": 266,
  "engagement_label": "high",
  "key_phrases": [
    "Phase 3 clinical trial",
    "avexitide",
    "post-bariatric hypoglycemia",
    "bariatric surgery",
    "low blood sugar episodes"
  ],
  "bariatric_context": "strong",
  "relevance_label": "relevant",
  "relevance_confidence": 0.9,
  "relevance_reason": "PBH explicitly mentioned with treatment context",
  "audience_label": "industry",
  "audience_confidence": 0.9,
  "themes": [
    "Treatments",
    "Conditions/Diagnosis",
    "Bariatric Surgery"
  ],
  "sentiment_label": "neutral",
  "sentiment_confidence": 0.8,
  "sentiment_raw": null,
  "emotions": [],
  "intent": [
    "news"
  ],
  "flags": [],
  "debug_matches": [
    "companies_Amylyx_003",
    "treatments_avexitide_024",
    "conditions_PBH_008",
    "topics_bariatric_surgery_034",
    "topics_clinical_trial_044"
  ]
}